GPT and metabolic dysfunction-associated steatotic liver disease: NAFLD patients were seven males and five females, aged 51 ± 14 years, had a body mass index (BMI) of 31.1 ± 4.0 kg/m2, plasma alanine aminotransferase (ALT) concentration of 43 ± 29 U/L, plasma total cholesterol of 182 ± 30.4 mg/dl, liver stiffness and a controlled attenuation parameter measured by FibroScan® of 7.1 ± 1.9 kPa and 297 ± 45 dB/m, respectively.